Duccio Medini, Phd Email and Phone Number
Duccio Medini, Phd work email
- Valid
- Valid
- Valid
Duccio Medini, Phd personal email
- Valid
- Valid
Transforming Health with mRNA and Data Science.Pharma Executive, R&D-board experience from discovery to life cycle management, contributed to the successful approval of several vaccines, including the first universal vaccine against serogroup B meningitis. Data Science and Vaccinology leader. Currently mRNA Program Director at Wellcome Leap and Data Science Strategic Director at Toscana Life Sciences Foundation.Visionary leadership style, across continents and disciplines. Success record in biological innovation, digital & analytics transformation, data strategy design & implementation, team building & talent development, sourcing strategy optimisation.PhD in Computational Physics, strong publication record in Vaccinology, Genomics and Population Biology, Full Professor of Molecular Biology, founder of Pangenomics. International thought leadership and collaboration network across academia, public health, regulatory authorities and industry.Board member of the WHO mRNA Hub program and CINI’s Italian National Digital Health Lab, Honorary member of the Cuban Immunology Society, Fellow of the ISI Foundation; an IMD, ADVAC and UC Berkley alumnus.
Pitt Bioforge
View- Website:
- pittbioforge.org
- Employees:
- 8
-
Pitt BioforgeSiena, It
-
R3 Program DirectorWellcome Leap Mar 2021 - PresentLos Angeles, Ca, UsProgram Director -
Data Science Strategic Director, Seconded To Wellcome LeapToscana Life Sciences Foundation Mar 2021 - PresentSiena, Siena, It -
Fellow / Associated Research ScientistIsi Foundation Jun 2011 - Mar 2021Torino, Piemonte, It- Developed end-to-end Data Science Strategy for Vaccines R&D. - Developed high-power vaccine effectiveness estimator based on Real World Evidence (RWE) and stochastic simulations. -
Senior Director, Head Data Science And Digital InnovationGsk - Vaccines R&D Nov 2019 - Jan 2021Brentford, Middlesex, GbLeading a global team of ~45 Data Scientists and Digital Innovators across multiple locations in Europe and US.Key focus on Personalised-, Systems- and Computational-Vaccinology, Bioinformatics and Machine Learning, Digital Innovation from early discovery, into clinical research and life cycle management on the market. -
Senior Director, Head Data Science And Clinical SystemsGsk - Vaccines R&D Sep 2015 - Oct 2019Brentford, Middlesex, Gb- Managed Novartis-GSK integration designing and leading team of 400+ in 6 sites (Europe, US, India) for Advanced Analytics, Data Management, Data Standards and Programming, Clinical Systems. Engagement index: 44% -> 79% in 12 months. Budget ~ 30M£/year.- Transformed Data Management sourcing strategy, Satisfaction index: 52% -> 81% in 18 months. Data Management delivery to plan >85% in 18 months, >95% in 3 years.- Implemented Data Governance, achieved >80% Standardization across clinical portfolio, <1.5 amendments per study.- Optimized clinical performance, overall delivery to plan: 45% -> 80% in 24 months.- Digital transformation of Discovery and Development: 72% successful Advanced Analytics POCs.
-
Director, Head Quantitative Sciences, Head Exploratory Biostatistics & Data Management, Vaccines R&DNovartis Vaccines Dec 2013 - Aug 2015Basel, Baselstadt, Ch• Lead a global team of 20+ scientists and statisticians responsible for BIoinformatics, Biostatistics, Data Sciences, Systems Biology/Vaccinology and Population Genomics.• Lead a global, cross-functional Exploratory Biostatistics and Data Management team for Vaccines Early Clinical Development• Led technical interactions with regulatory agencies (FDA, EMA, Health Canada, TGA) and public health/ recommending bodies (CDC, PH England, ATAGI, QPID, JCVI). -
Global Head, Quantitative BiologyNovartis Vaccines Feb 2011 - Dec 2013Basel, Baselstadt, Ch• Lead innovation by developing systems approaches to R&D projects (Bioinformatics, Biostatistics, Translational Modeling).• Managed a global team of 10 scientists and statisticians, as well as external consultants.• Represented the Research Division in Global Project Teams to inform strategic decisions.• Lead an international scientific and public health collaboration of 60+ team members, theMeningococcal Antigen Typing System (MATS) platform, in Europe, the Americas, and Australia.• Integrated biological, clinical and -omics data to foster vaccine discovery.• Optimized experimental design, develop assays and data analysis approaches.• Developed computational models of biological networks and vaccine performance.
-
Head, Genomics Ii LaboratoryNovartis Vaccines Jun 2008 - Feb 2011Basel, Baselstadt, Ch• Led an international genome sequencing project: 6 academic and corporate partners, and a budget of 2.000.000 $US.• Designed and managed immunoassay development, qualification and inter-laboratory standardization across an international network including 6 academic and public health partners.• Biostatistics and Modeling for clinical development and regulatory interactions: Bexsero® vaccine (Phase I to III clinical studies, registration) and pandemic influenza vaccine.• Developed a predictive framework for long-term vaccine efficacy based on short-term estimates.• Supervised, mentored and coached 7 scientists/statisticians.
-
Adjunct Professor Of Bioinformatics And BiostatisticsUniversity Of Perugia Oct 2010 - Aug 2015Perugia, Perugia, It -
Staff ScientistChiron Corporation - Novartis Vaccines And Diagnostics Jun 2004 - May 2008Emeryville, California, Us• Developed the pan-genome concept for Streptococcus agalactiae and other bacterial species.• Developed, validated and patented a novel algorithm for unsupervised classification of proteins into Families, the PHN-Families database. -
Research ScientistChiron Corporation - Novartis Vaccines And Diagnostics Jun 2001 - May 2004Emeryville, California, Us• Designed and deployed an SRS-based network of biological databases.• EU IST Project: “BIOwulf, Speeding-up Biocomputing applications using a commodity-based parallelcomputer”, collaboration Chiron SpA – CIRB (University of Bologna, Italy).
Duccio Medini, Phd Skills
Duccio Medini, Phd Education Details
-
ImdExecutive Leadership -
University Of California, Berkeley, Haas School Of BusinessLeadership For Scientists
-
Northeastern UniversityBiophysics
-
Università Degli Studi Di PerugiaBiophysics
-
Università Degli Studi Di PerugiaTheoretical Physics
-
Liceo Scientifico Galileo GalileiMaturità Scientifica
Frequently Asked Questions about Duccio Medini, Phd
What company does Duccio Medini, Phd work for?
Duccio Medini, Phd works for Pitt Bioforge
What is Duccio Medini, Phd's role at the current company?
Duccio Medini, Phd's current role is R3 Program Director @ Wellcome Leap.
What is Duccio Medini, Phd's email address?
Duccio Medini, Phd's email address is du****@****ail.com
What schools did Duccio Medini, Phd attend?
Duccio Medini, Phd attended Imd, University Of California, Berkeley, Haas School Of Business, Northeastern University, Università Degli Studi Di Perugia, Università Degli Studi Di Perugia, Liceo Scientifico Galileo Galilei.
What skills is Duccio Medini, Phd known for?
Duccio Medini, Phd has skills like Bioinformatics, Vaccines, Genomics, Life Sciences, Clinical Development, Biostatistics, Biotechnology, Pharmaceutical Industry, Assay Development, R&d, Infectious Diseases, Computational Biology.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial